Apex Healthcare Bhd (XKLS:7090) Piotroski F-Score: 7 (As of Jun. 27, 2026) — 40% Above Median


XKLS:7090 Apex Healthcare Bhd XKLS:7090
63 GF Score
Price RM2.61
GF Value RM2.27
! 7 Warning Signs
View Full Analysis

What is Apex Healthcare Bhd Piotroski F-Score?

Apex Healthcare Bhd XKLS:7090 63 Piotroski F-Score is 7 as of Jun. 27, 2026, which is 40% above its 10-year median of 5.00. GuruFocus rates XKLS:7090 with a GF Score™ of 63/100 and a GF Value™ of RM2.27. The stock has 7 warning signs investors should review.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Apex Healthcare Bhd has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Apex Healthcare Bhd's Piotroski F-Score or its related term are showing as below:

XKLS:7090' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 8
Current: 7

During the past 13 years, the highest Piotroski F-Score of Apex Healthcare Bhd was 8. The lowest was 2. And the median was 5.

Apex Healthcare Bhd  (XKLS:7090) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Apex Healthcare Bhd Piotroski F-Score Related Terms


Apex Healthcare Bhd Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Apex Healthcare Bhd's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apex Healthcare Bhd Piotroski F-Score Chart

Apex Healthcare Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 6.00 6.00 6.00 3.00

Apex Healthcare Bhd Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 3.00 5.00 7.00 7.00

XKLS:7090 vs MCK, COR, CAH: Piotroski F-Score Comparison

For the Medical Distribution subindustry, Apex Healthcare Bhd's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apex Healthcare Bhd Piotroski F-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Apex Healthcare Bhd's Piotroski F-Score falls into.


XKLS:7090
63GF Score
Apex Healthcare Bhd XKLS:7090
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep25) TTM:Last Year (Sep24) TTM:
Net Income was 13.461 + 17.584 + 18.818 + 15.6 = RM65.5 Mil.
Cash Flow from Operations was 33.679 + 18.921 + 9.242 + 29.411 = RM91.3 Mil.
Revenue was 237.501 + 238.87 + 240.752 + 253.019 = RM970.1 Mil.
Gross Profit was 56.51 + 55.568 + 58.819 + 56.279 = RM227.2 Mil.
Average Total Assets from the begining of this year (Sep24)
to the end of this year (Sep25) was
(1023.842 + 1008.886 + 1025.061 + 1018.416 + 998.296) / 5 = RM1014.9002 Mil.
Total Assets at the begining of this year (Sep24) was RM1,023.8 Mil.
Long-Term Debt & Capital Lease Obligation was RM40.9 Mil.
Total Current Assets was RM559.0 Mil.
Total Current Liabilities was RM166.9 Mil.
Net Income was 20.061 + 21.209 + 23.643 + 18.231 = RM83.1 Mil.

Revenue was 239.997 + 248.178 + 238.735 + 237.366 = RM964.3 Mil.
Gross Profit was 51.599 + 55.765 + 56.036 + 57.284 = RM220.7 Mil.
Average Total Assets from the begining of last year (Sep23)
to the end of last year (Sep24) was
(1098.49 + 1122.617 + 1145.715 + 991.003 + 1023.842) / 5 = RM1076.3334 Mil.
Total Assets at the begining of last year (Sep23) was RM1,098.5 Mil.
Long-Term Debt & Capital Lease Obligation was RM51.3 Mil.
Total Current Assets was RM548.9 Mil.
Total Current Liabilities was RM166.8 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Apex Healthcare Bhd's current Net Income (TTM) was 65.5. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Apex Healthcare Bhd's current Cash Flow from Operations (TTM) was 91.3. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep24)
=65.463/1023.842
=0.06393858

ROA (Last Year)=Net Income/Total Assets (Sep23)
=83.144/1098.49
=0.07568936

Apex Healthcare Bhd's return on assets of this year was 0.06393858. Apex Healthcare Bhd's return on assets of last year was 0.07568936. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Apex Healthcare Bhd's current Net Income (TTM) was 65.5. Apex Healthcare Bhd's current Cash Flow from Operations (TTM) was 91.3. ==> 91.3 > 65.5 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep24 to Sep25
=40.941/1014.9002
=0.04033993

Gearing (Last Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=51.286/1076.3334
=0.0476488

Apex Healthcare Bhd's gearing of this year was 0.04033993. Apex Healthcare Bhd's gearing of last year was 0.0476488. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep25)=Total Current Assets/Total Current Liabilities
=559.007/166.87
=3.34995505

Current Ratio (Last Year: Sep24)=Total Current Assets/Total Current Liabilities
=548.911/166.813
=3.29057687

Apex Healthcare Bhd's current ratio of this year was 3.34995505. Apex Healthcare Bhd's current ratio of last year was 3.29057687. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Apex Healthcare Bhd's number of shares in issue this year was 715.665. Apex Healthcare Bhd's number of shares in issue last year was 715.497. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=227.176/970.142
=0.23416778

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=220.684/964.276
=0.22885979

Apex Healthcare Bhd's gross margin of this year was 0.23416778. Apex Healthcare Bhd's gross margin of last year was 0.22885979. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep24)
=970.142/1023.842
=0.9475505

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep23)
=964.276/1098.49
=0.87781955

Apex Healthcare Bhd's asset turnover of this year was 0.9475505. Apex Healthcare Bhd's asset turnover of last year was 0.87781955. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+0+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Apex Healthcare Bhd has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Apex Healthcare Bhd (XKLS:7090) has a Piotroski F-Score of 7 as of Jun. 27, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Apex Healthcare Bhd and its competitors. This is 40% above median its historical median of 5.00. Over the past decade, Apex Healthcare Bhd's Piotroski F-Score has ranged from 2.00 to 8.00.
Is Apex Healthcare Bhd's Piotroski F-Score too high?
Apex Healthcare Bhd's current Piotroski F-Score of 7 is 40% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Medical Distribution industry median Piotroski F-Score is 5.00. Apex Healthcare Bhd's value of 7 is 40% above this industry median. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's Piotroski F-Score compare to MCK and COR?
Apex Healthcare Bhd's Piotroski F-Score of 7 can be compared against companies in the Medical Distribution industry. The industry median Piotroski F-Score is 5.00. Apex Healthcare Bhd's value of 7 is 40% above this benchmark. Historically, Apex Healthcare Bhd's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Apex Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Distribution company?
The median Piotroski F-Score among Medical Distribution companies is 5.00, based on 114 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Healthcare Bhd's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Apex Healthcare Bhd and its competitors. For the Medical Distribution industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current Piotroski F-Score is 7, which is 40% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current Piotroski F-Score of 7. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current Piotroski F-Score is 7, which is 40% above median its 10-year median of 5.00 and 40% above the Medical Distribution industry median of 5.00. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current Piotroski F-Score is 7 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?

Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued. The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.

Key valuation signals for XKLS:7090:

  • Piotroski F-Score: 7 (40% above median its 10-year median of 5.00)
  • GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
  • GF Score™: 63/100 with 7 warning signs
  • Industry Position: 40% above the Medical Distribution median

No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Apex Healthcare Bhd Business Description

Address 1-5 Jalan TTC 1, Cheng Industrial Estate, Melaka, MLA, MYS, 75250
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score

Get the complete analysis for XKLS:7090

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM2.61
Price
RM2.27
GF Value